
Foresight Mental Health
Foresight | Mental Health | Affordable and Advanced Care.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor | €0.0 | round |
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor investor investor investor investor investor investor investor investor investor investor | €0.0 | round | |
N/A | Series C | ||
Total Funding | 000k |
Related Content
Foresight Mental Health emerged from the shared vision of Doug Hapeman and Matt Milford, who met in a computer science class at the University of California, Berkeley. Their journey began with personal encounters with the complexities of the mental health system, which fueled their mission. Initially conceived in 2018 as a software company to aid psychiatric prescribing decisions, the business model pivoted after facing challenges with provider adoption. Undeterred, Hapeman and Milford transitioned the company into a direct healthcare provider, integrating their technology in-house to create a data-centric approach to mental healthcare.
Operating as a full-service mental health provider, Foresight serves individuals, couples, and families across various age groups. The company provides care through both telehealth and in-person services at its physical clinics, accepting most major insurance carriers to enhance affordability and access. Revenue is generated through reimbursement for its clinical services. Foresight’s target market includes a broad patient population, with an initial focus on university students. After a period of rapid expansion and financial challenges that led to a workforce reduction and a leadership change in 2022, the company has since refocused its operations.
Foresight delivers a comprehensive suite of mental health services, including psychotherapy, psychiatry and medication management, neuropsychology, and nutritional counseling. Its data-informed methodology involves creating personalized patient profiles that analyze genetics, symptoms, and lifestyle to inform treatment plans. The company leverages technology, such as wearables, to gather data and monitor patient progress, aiming to deliver value-based care. For specific conditions, Foresight offers advanced treatments like transcranial magnetic stimulation (TMS) and ketamine therapy for treatment-resistant depression. The company also provides more structured programs, such as intensive outpatient (IOP) and partial hospitalization programs (PHP), for individuals requiring a higher level of support.
Keywords: mental healthcare, psychiatry, psychotherapy, telehealth, medication management, data-driven healthcare, value-based care, neuropsychology, nutritional counseling, transcranial magnetic stimulation, intensive outpatient program, behavioral health, personalized treatment, mental wellness, insurance-based care, clinical services, patient outcomes, Doug Hapeman, Matt Milford, Berkeley startup